Four months after calling for the resignation of four board members from Assertio Holdings ... The allegations surround ...

The FDA granted Aduhelm an accelerated approval, meaning that Biogen has to carry out a post-marketing trial to confirm that it is effective, but critics say results from that will be years away.

But that effort is going to run into a major roadblock: the “deep state.” The phrase deep state might trigger images of tinfoil hats. After all, Trump has spent much of the past eight years falsely ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR) and reminds investors ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

The reactions to Donald's Trump's victory across the crypto, currency, and stock markets. Super Micro's woes, and the outlook for a company with no auditor, no annual report and, perhaps soon, no ...

A second Trump administration presents a dilemma for scientists and career staff at top federal health agencies: stay and ...

Detailed price information for Spectral Medical Inc (EDT-T) from The Globe and Mail including charting and trades.

Through a collaboration with the National Institutes of Health, Trevena is also exploring TRV045 as a potential treatment for epilepsy. S1P receptors are located throughout the body, including the ...

In return for his backing when Kennedy largely dropped his independent presidential bid, Trump has said he would allow Kennedy "to run wild" on healthcare, without offering details.

Following a hotly contested election, Donald Trump is once again the president-elect and will return to the White House on ...